231 related articles for article (PubMed ID: 27358173)
1. Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.
Briguori C; Madonna R; Zimarino M; Calabrò P; Quintavalle C; Salomone M; Condorelli G; De Caterina R
Cardiovasc Drugs Ther; 2016 Oct; 30(5):465-472. PubMed ID: 27358173
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
[TBL] [Abstract][Full Text] [Related]
3. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
[TBL] [Abstract][Full Text] [Related]
4. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study).
Eisen A; Leshem-Lev D; Yavin H; Orvin K; Mager A; Rechavia E; Bental T; Dadush O; Battler A; Kornowski R; Lev EI
Cardiovasc Drugs Ther; 2015 Apr; 29(2):129-35. PubMed ID: 25712416
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials.
Pan Y; Tan Y; Li B; Li X
Lipids Health Dis; 2015 Aug; 14():97. PubMed ID: 26306625
[TBL] [Abstract][Full Text] [Related]
6. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
Nafasi L; Rahmani R; Shafiee A; Salari A; Abdollahi A; Meysamie A
Curr Med Res Opin; 2014 Mar; 30(3):381-6. PubMed ID: 23952289
[TBL] [Abstract][Full Text] [Related]
7. The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy.
Madonna R; Renna FV; Lanuti P; Perfetti M; Marchisio M; Briguori C; Condorelli G; Manzoli L; De Caterina R
PLoS One; 2017; 12(4):e0172800. PubMed ID: 28394933
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
[TBL] [Abstract][Full Text] [Related]
9. Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.
Chen Y; Li D; Jing J; Yan H; Liu J; Shen Z; James S; Varenhorst C
Clin Ther; 2017 Sep; 39(9):1827-1839.e1. PubMed ID: 28807393
[TBL] [Abstract][Full Text] [Related]
10. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
He W; Cao M; Li Z
Drug Dev Res; 2020 Aug; 81(5):551-556. PubMed ID: 32142170
[TBL] [Abstract][Full Text] [Related]
11. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
[TBL] [Abstract][Full Text] [Related]
13. Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin.
Cay S; Cagirci G; Sen N; Balbay Y; Durmaz T; Aydogdu S
Cardiovasc Drugs Ther; 2010 Feb; 24(1):41-7. PubMed ID: 20217203
[TBL] [Abstract][Full Text] [Related]
14. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
15. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis.
Ebrahimi R; Saleh J; Toggart E; Shah AP; Azmoon S; Babaei H; Lee J; Smith R; Movahed MR; Rubin SA
J Invasive Cardiol; 2008 Jun; 20(6):292-5. PubMed ID: 18523323
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Trial of Creatine-kinase Leak After Rosuvastatin in Elective Percutaneous Coronary Intervention (CLEAR-PCI).
Martins KB; Mattos LA; Sousa AG; Sousa JE; Abzaid A; Feres F; de Ribamar JC; Staico R; Costa RA; Chaves AJ
J Interv Cardiol; 2015 Aug; 28(4):339-47. PubMed ID: 26086603
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
[TBL] [Abstract][Full Text] [Related]
18. Effects of rosuvastatin and atorvastatin on nonsustained ventricular tachycardia in patients with ST-elevation myocardial infarction: a retrospective analysis.
Hu X; Cheng J; Li C
Eur J Clin Pharmacol; 2018 Jan; 74(1):29-35. PubMed ID: 28965256
[TBL] [Abstract][Full Text] [Related]
19. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
20. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.
Briguori C; Colombo A; Airoldi F; Violante A; Focaccio A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Bonizzoni E; Ricciardelli B
Eur Heart J; 2004 Oct; 25(20):1822-8. PubMed ID: 15474697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
